Home/Filings/4/0001437749-24-035868
4//SEC Filing

Nassif Freda 4

Accession 0001437749-24-035868

CIK 0001069530other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:35 PM ET

Size

5.2 KB

Accession

0001437749-24-035868

Insider Transaction Report

Form 4
Period: 2024-11-18
Nassif Freda
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-11-18+100,000100,000 total
    Exercise: $27.95Exp: 2034-11-18Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025.

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1
  • filerCIK 0002045036

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:35 PM ET
Size
5.2 KB